文献速递睡眠呼吸障碍

睡眠呼吸暂停特异性脉率反应预测心血管疾病发病与死亡

The Sleep Apnea-Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

该研究在MESA(N=1395)和SHHS(N=4575)中测量呼吸暂停低通气相关脉率反应(ΔHR),发现ΔHR与亚临床心血管生物标志物呈U型关系,高ΔHR者非致命或致命心血管疾病及全因死亡风险增加,尤其在缺氧负荷大且非嗜睡者中。

要点

  • 高ΔHR与亚临床心血管生物标志物升高相关,呈U型关系。
  • 高ΔHR者非致命或致命心血管疾病及全因死亡风险增加。
  • 高ΔHR的风险在缺氧负荷大且非嗜睡个体中尤为显著。

核心结论

  • 阻塞性睡眠呼吸暂停患者中,ΔHR升高者心血管疾病发病和死亡风险增加。
  • ΔHR可作为风险分层和未来临床试验患者选择的预后生物标志物。

研究设计与样本

  • 研究测量MESA(N=1,395)和SHHS(N=4,575)中的ΔHR。
  • MESA数据用于确定ΔHR与亚临床心血管生物标志物的关联形式。
  • SHHS纵向数据用于检验ΔHR与非致命或致命心血管疾病及全因死亡的关联。

主要发现

  • MESA中,亚临床心血管生物标志物(冠状动脉钙化、NT-proBNP、Framingham风险评分)与ΔHR呈U型关系。
  • SHHS中,高ΔHR(上四分位)相比中段ΔHR(25-75百分位),非致命心血管疾病调整风险比1.60(95%CI 1.28-2.00)。
  • 高ΔHR相比中段ΔHR,致命心血管疾病调整风险比1.68(95%CI 1.22-2.30),全因死亡调整风险比1.29(95%CI 1.07-1.55)。
  • 缺氧负荷大者中,高ΔHR的非致命心血管疾病风险比1.93(95%CI 1.36-2.73),致命心血管疾病风险比3.50(95%CI 2.15-5.71),全因死亡风险比1.84(95%CI 1.40-2.40)。
  • 高ΔHR相关风险仅在非嗜睡个体中观察到。

临床怎么用

  • 对阻塞性睡眠呼吸暂停患者可考虑测量ΔHR以辅助心血管风险分层。
  • 高ΔHR且缺氧负荷大的非嗜睡患者可能需更积极的心血管风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Randomized controlled trials have been unable to detect a cardiovascular benefit of continuous positive airway pressure in unselected patients with obstructive sleep apnea (OSA). We hypothesize that deleterious cardiovascular outcomes are concentrated in a subgroup of patients with a heightened pulse-rate response to apneas and hypopneas (ΔHR). Methods: We measured the ΔHR in the MESA (Multi-Ethnic Study of Atherosclerosis) (N = 1,395) and the SHHS (Sleep Heart Health Study) (N = 4,575). MESA data were used to determine the functional form of the association between the ΔHR and subclinical cardiovascular biomarkers, whereas primary analyses tested the association of the ΔHR with nonfatal or fatal cardiovascular disease (CVD) and all-cause mortality in longitudinal data from the SHHS. Measurements and Main Results: In the MESA, U-shaped relationships were observed between subclinical CVD biomarkers (coronary artery calcium, NT-proBNP [N-terminal prohormone BNP], and Framingham risk score) and the ΔHR; notably, a high ΔHR (upper quartile) was associated with elevated biomarker scores compared with a midrange ΔHR (25th-75th centiles). In the SHHS, individuals with a high ΔHR compared with a midrange ΔHR were at increased risk of nonfatal or fatal CVD and all-cause mortality (nonfatal adjusted hazard ratio [95% confidence interval (CI)], 1.60 [1.28-2.00]; fatal adjusted hazard ratio [95% CI], 1.68 [1.22-2.30]; all-cause adjusted hazard ratio [95% CI], 1.29 [1.07-1.55]). The risk associated with a high ΔHR was particularly high in those with a substantial hypoxic burden (nonfatal, 1.93 [1.36-2.73]; fatal, 3.50 [2.15-5.71]; all-cause, 1.84 [1.40-2.40]) and was exclusively observed in nonsleepy individuals. Conclusions: Individuals with OSA who demonstrate an elevated ΔHR are at increased risk of cardiovascular morbidity and mortality. This study identifies a prognostic biomarker for OSA that appears useful for risk stratification and patient selection for future clinical trials.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Azarbarzin A, Sands SA, Younes M, et al. The Sleep Apnea-Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality. Am J Respir Crit Care Med. 2021. PMID: 33406013. doi:10.1164/rccm.202010-3900OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。